Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Burkitt Lymphoma 2Tumor Lysis Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hyperuricemia 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Blast Crisis 1

Interventions

fludarabine phosphate 23Cyclophosphamide 23Whole-Body Irradiation 20Mycophenolic Acid 17Peripheral Blood Stem Cell Transplantation 15Busulfan 14Cyclosporine 12Tacrolimus 10Melphalan 10Antilymphocyte Serum 9Cord Blood Stem Cell Transplantation 7Rituximab 6Radiotherapy 6Methotrexate 6Filgrastim 6Etoposide 6fludarabine 5Methylprednisolone 5Granulocyte Colony-Stimulating Factor 4Vincristine 3Thiotepa 3Sirolimus 3Prednisone 3Methylprednisolone Hemisuccinate 3Methylprednisolone Acetate 3Doxorubicin 3Cytarabine 3Carboplatin 3Alemtuzumab 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Dendritic Cell Sarcoma, Interdigitating × Urate Oxidase × Clear all
NCT00057811 2014-09-19

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Children's Oncology Group

Phase 2 Completed
97 enrolled 13 charts
LymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡